Furthermore, GSEA analyses indicated that patients with high levels of RRM2 exhibited enrichment in various biological processes and pathways, including cell cycle, p2 signaling pathway, DNA replication, small cell lung cancer, apoptosis, and cancer pathways. This evidence concerns the gene RRM2 and cancer.